JP2003519228A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519228A5
JP2003519228A5 JP2001550222A JP2001550222A JP2003519228A5 JP 2003519228 A5 JP2003519228 A5 JP 2003519228A5 JP 2001550222 A JP2001550222 A JP 2001550222A JP 2001550222 A JP2001550222 A JP 2001550222A JP 2003519228 A5 JP2003519228 A5 JP 2003519228A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
general formula
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001550222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519228A (ja
JP3869723B2 (ja
Filing date
Publication date
Priority claimed from GBGB0000079.4A external-priority patent/GB0000079D0/en
Application filed filed Critical
Publication of JP2003519228A publication Critical patent/JP2003519228A/ja
Publication of JP2003519228A5 publication Critical patent/JP2003519228A5/ja
Application granted granted Critical
Publication of JP3869723B2 publication Critical patent/JP3869723B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001550222A 2000-01-05 2001-01-04 バソプレッシン・アゴニストとしての縮合アゼピン Expired - Fee Related JP3869723B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0000079.4A GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents
GB0000079.4 2000-01-05
PCT/GB2001/000023 WO2001049682A1 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005366100A Division JP3813629B2 (ja) 2000-01-05 2005-12-20 バソプレッシン・アゴニストとしての縮合アゼピン

Publications (3)

Publication Number Publication Date
JP2003519228A JP2003519228A (ja) 2003-06-17
JP2003519228A5 true JP2003519228A5 (enExample) 2006-02-23
JP3869723B2 JP3869723B2 (ja) 2007-01-17

Family

ID=9883168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001550222A Expired - Fee Related JP3869723B2 (ja) 2000-01-05 2001-01-04 バソプレッシン・アゴニストとしての縮合アゼピン
JP2005366100A Expired - Fee Related JP3813629B2 (ja) 2000-01-05 2005-12-20 バソプレッシン・アゴニストとしての縮合アゼピン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005366100A Expired - Fee Related JP3813629B2 (ja) 2000-01-05 2005-12-20 バソプレッシン・アゴニストとしての縮合アゼピン

Country Status (34)

Country Link
US (3) US7074781B2 (enExample)
EP (1) EP1248784B1 (enExample)
JP (2) JP3869723B2 (enExample)
KR (1) KR100605466B1 (enExample)
CN (1) CN1183129C (enExample)
AR (1) AR035327A1 (enExample)
AT (1) ATE366730T1 (enExample)
AU (1) AU777538B2 (enExample)
BR (1) BR0107414B1 (enExample)
CA (1) CA2396277C (enExample)
CY (1) CY1108034T1 (enExample)
CZ (1) CZ303444B6 (enExample)
DE (1) DE60129298T2 (enExample)
DK (1) DK1248784T3 (enExample)
EE (1) EE200200367A (enExample)
ES (1) ES2288923T3 (enExample)
GB (1) GB0000079D0 (enExample)
HK (1) HK1046910B (enExample)
HR (1) HRP20020481B1 (enExample)
HU (1) HU229937B1 (enExample)
IL (1) IL149528A0 (enExample)
MX (1) MXPA02006546A (enExample)
MY (1) MY140467A (enExample)
NO (1) NO322571B1 (enExample)
NZ (1) NZ518803A (enExample)
PL (1) PL211341B1 (enExample)
PT (1) PT1248784E (enExample)
RU (1) RU2259367C2 (enExample)
SI (1) SI1248784T1 (enExample)
SK (1) SK287005B6 (enExample)
UA (1) UA73152C2 (enExample)
UY (1) UY26521A1 (enExample)
WO (1) WO2001049682A1 (enExample)
ZA (1) ZA200205180B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5803659A (en) 1995-12-08 1998-09-08 Chattey; Nigel Modular caissons for use in constructing, expanding and modernizing ports and harbors.
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
AU2001252222B2 (en) * 2000-03-27 2006-11-02 Merck Serono Sa Pharmaceutically active pyrrolidine derivatives as bax inhibitors
EA006424B1 (ru) * 2000-03-27 2005-12-29 Апплайд Резеч Системз Арс Холдинг Н.В. Фармацевтически активные производные пирролидина
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
NZ542815A (en) 2003-04-28 2009-01-31 Astellas Pharma Inc 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof
DE60305043T2 (de) * 2003-11-13 2006-11-30 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
EP1813603A1 (en) * 2004-11-17 2007-08-01 Kissei Pharmaceutical Co., Ltd. Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
JP5009785B2 (ja) * 2005-03-25 2012-08-22 キッセイ薬品工業株式会社 ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途
WO2007052517A1 (ja) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited ヒドロキシ-2-ピロリジンカルボキシアミド化合物の製法
WO2008038600A1 (en) * 2006-09-25 2008-04-03 Kissei Pharmaceutical Co., Ltd. 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
CN101686983A (zh) * 2007-05-10 2010-03-31 Amr科技公司 芳基和杂芳基取代的四氢苯并-1,4-二氮杂䓬及其阻断去甲肾上腺素、多巴胺和5-羟色胺重摄取的用途
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3225250T3 (da) * 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960886A (en) 1968-07-03 1976-06-01 Sterling Drug Inc. Substituted N-arylanilines
CH599752A5 (enExample) 1973-04-18 1978-05-31 Ciba Geigy Ag
CA1047490A (en) 1973-04-18 1979-01-30 Friedrich Karrer Ethers
DE2355454A1 (de) 1973-11-07 1976-10-07 Paul Geisslinger Lochmaschine
EP0186817B1 (en) 1984-12-10 1989-08-02 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
WO1991005549A1 (en) 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5753677A (en) 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
CA2066104C (en) 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
JPH05320135A (ja) * 1992-05-19 1993-12-03 Yamanouchi Pharmaceut Co Ltd テトラヒドロベンズアゼピン誘導体
US5498609A (en) 1992-08-20 1996-03-12 Otsuka Pharmaceutical Company, Limited Benzoazepinyl compounds as oxytocin and vasopressin antagonists
TW270927B (enExample) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
WO1994012476A1 (fr) * 1992-11-25 1994-06-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de benzanilide
WO1994020473A1 (fr) * 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compose avec action antagoniste de la vasopressine
GB9307527D0 (en) 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5760031A (en) 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5968930A (en) 1993-07-29 1999-10-19 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5516774A (en) 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5843952A (en) 1993-07-29 1998-12-01 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US6403577B1 (en) * 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
FI1215U1 (fi) * 1993-12-03 1994-02-21 Valmet Paper Machinery Inc Anlaeggning i samband med styrningen av en vira
FR2716194B1 (fr) * 1994-02-14 1996-05-31 Sanofi Elf Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.
WO1995031034A2 (en) * 1994-05-06 1995-11-16 Philips Electronics N.V. Microwave transmission system
DK1221440T3 (da) 1994-06-15 2007-09-17 Otsuka Pharma Co Ltd Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer
JP2926335B2 (ja) * 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
EP1000059B1 (en) * 1997-07-30 2004-09-29 Wyeth Tricyclic vasopressin agonists
JP4338305B2 (ja) * 1997-07-30 2009-10-07 ワイス 三環系バソプレシンアゴニスト
ES2216579T3 (es) 1998-10-09 2004-10-16 Janssen Pharmaceutica N.V. Derivados de 4,5-dihidro-isoxazol y su uso farmaceutico.
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
DE10033337A1 (de) 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB0120051D0 (en) 2001-08-16 2001-10-10 Ferring Bv Oxytocin agonists
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1449844A1 (en) 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP1627876A1 (en) 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
US7341963B2 (en) * 2005-05-17 2008-03-11 Milliken & Company Non-woven material with barrier skin

Similar Documents

Publication Publication Date Title
JP2003519228A5 (enExample)
JP2002532392A5 (enExample)
JP2006526590A5 (enExample)
JP2003509349A5 (enExample)
JP2004514663A5 (enExample)
JP2001526218A5 (enExample)
JP2006503850A5 (enExample)
JP2008501705A5 (enExample)
JP2006523216A5 (enExample)
JP2002519434A5 (enExample)
JP2004504406A5 (enExample)
JP2012525393A5 (enExample)
JP2006507220A5 (enExample)
RU2002120798A (ru) Конденсированные азепины в качестве агонистов вазопрессина
JP2010511701A5 (enExample)
JP2002519425A5 (enExample)
JP2006516643A5 (enExample)
JP2002544227A5 (enExample)
JP2002534477A (ja) メラガトランの新規使用
JP2002534477A5 (enExample)
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors
JP2007525533A5 (enExample)
JP2002540148A5 (enExample)
JP2003528144A5 (enExample)
JPH1087484A5 (enExample)